CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding CalciMedica, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 13 | 0 |
| Shares | 678.6K | 591.8K | −86.8K (−12.8%) |
| Value | $2.72M | $1.56M | −$1.16M (−42.6%) |
New holders (3)
Institutions that held CalciMedica, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hudson Bay Capital Management LP | 166,857 | $432.2K | 0.00% |
| Geode Capital Management, LLC | 13,354 | $34.6K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $3 | 0.00% |
Sold out (3)
Institutions that held CalciMedica, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 265,657 | $1.07M |
| GWM Advisors LLC | 71 | $285 |
| Gradient Investments LLC | 13 | $52 |